Navigation Links


XXI at Biology News

XXI at Biology Products
XXI at Biology Technology
XXI at Medicine News
XXI at Medicine Products

Maxxis™ 300

Description:The Maxxis™ 300 is a healthcare bed system which helps provide comfort and safety for individuals in the home care setting INDICATIONS: Patients weighing up to 600 lbs.(or combined weight of 2) Healthcare frame accommodating one or two individuals, depending on frame size selected CONTRAINDICATIONS: Total weight in excess of 600 lbs. (including accessories)<b...
Company:Kinetic Concepts, Inc.

Maxxis™ 400

Description:The Maxxis™ 400 is a bariatric bed system which helps provide comfort and safety for individuals in the home care setting INDICATIONS: Patients weighing up to 1000 lbs. (or combined weight of 2) Healthcare frame accommodating one or two individuals, depending on frame size selected CONTRAINDICATION: Total weight in excess of 1000 lbs. (including accessories...
Company:Kinetic Concepts, Inc.

AirMaxxis™

Description:KCIs AirMaxxis™ is a pressure relief mattress overlay designed specifically for AirMaxxis frame. It provides low air loss therapy for those patient with skin breakdown or at risk for skin breakdown. INDICATIONS: Patients whose body weight and size pose a significant risk or care management issue to the patient or staff during the performance of routine nursing care...
Company:Kinetic Concepts, Inc.
XXI at Medicine Technology

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

RIDGEFIELD, Conn., July 11, 2007 /PRNewswire/ -- Phase 3 resultsfrom the RE-NOVATE(TM) trial demonstrated that oral dabigatranetexilate once daily, administered for an average of 33 days, wasnon-inferior to enoxaparin, also administered for an average of 33days, in preventing venous thromboembolism (VTE) and all-causemortality after total hip replacement surgery. In this trial, therate o...

Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis

HORSHAM, Pa.--(BUSINESS WIRE)--Jul 11, 2007 - Neose Technologies,Inc. (Nasdaq GM:NTEC) today announced that two poster presentationswere presented with its collaborative partner, Novo Nordisk A/S,relating to GlycoPEGylated recombinant Factor VIIa at the XXIstCongress of the International Society on Thrombosis and Haemostasisin Geneva, Switzerland. The data presented demonstrates thatGlycoPE...

Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis

SAN FRANCISCO, July 10, 2007 /PRNewswire/ -- PortolaPharmaceuticals, Inc. announced positive Phase II data on its leadcompound, PRT054021, an oral Factor Xa inhibitor, today at the XXICongress of the International Society on Thrombosis and Haemostasis(ISTH) in Geneva, Switzerland. The EXPERT trial showed thatPRT054021 was safe, effective, and well tolerated for theprevention of venous th...

Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis

SAN CARLOS, Calif., July 5 /PRNewswire-FirstCall/ -- Nuvelo,Inc. (Nasdaq: NUVO) today announced that data from the ANTHEM(Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 Phase2 trial looking at recombinant nematode anticoagulant protein c2(rNAPc2) in patients with acute coronary syndromes (ACS),preclinical data evaluating rNAPc2 in mouse models of colorectalcancer, and precli...

Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)

SOUTH SAN FRANCISCO, July 02, 2007 /PRNewswire/ -- PortolaPharmaceuticals, Inc. announced today that it will present clinicaland preclinical data on its oral Factor Xa inhibitor and on itsintravenous and oral ADP receptor antagonist at the XXI Congress ofthe International Society of Thrombosis and Haemostasis (ISTH) inGeneva, Switzerland on July 6 through July 12, 2007. The EXPERT...
Other TagsMoHtape
(Date:11/18/2008)...and Miller Garner Prestigious Awards , , WA... L. Buc, Geoffrey M. Levitt, Dr. Murray M. Lumpkin...he 2009 Food and Drug Law Institute (FDLI) Disting...ed today. , , Since 1993, FDLI has selected...nd drug law: government, industry, law firms and c...
(Date:11/18/2008)...rocedure in which her stem cells were combined wit...scientists report , , TUESDAY, Nov. 18 (...ld mother of two has successfully undergone the fi...ed from a donor,s airway and her own stem cells, r...dia Castillo, who lives in Barcelona, Spain, with ...
(Date:11/18/2008)...PRNewswire-FirstCall/ -- Streamline Health Solutio...t will release third quarter of,fiscal year 2008 ... 2008 on,Tuesday, December 2, 2008 after the mark...l and web cast to discuss the results on Tuesday, ...parties can access the call by dialing (877) 356-5...
(Date:11/18/2008)... different molecular mechanisms, scientists show ,...Pain and itching are regulated by different molecu...ty study that challenges the long-held belief that...esponse to pain. , This finding could prove imp...nd pain. , Zhou-Feng Chen, of Washington Univer...
Breaking Medicine News(10 mins):Health News:FDLI Names 2009 Distinguished Service and Leadership Award Recipients 2Health News:FDLI Names 2009 Distinguished Service and Leadership Award Recipients 3Health News:FDLI Names 2009 Distinguished Service and Leadership Award Recipients 4Health News:Airway Transplant Aided by Stem Cells a Medical First 2Health News:Airway Transplant Aided by Stem Cells a Medical First 3Health News:Streamline Health to Announce Third Quarter of Fiscal Year 2008 Financial Results on Tuesday, December 2, 2008 2Health News:Itching Not a Less Intense Form of Pain 2
(Date:11/18/2008)...ers have created a new type of membrane that separ...ed for environmental cleanup, water purification a... would last longer than conventional filters for s...ater while beading oil, traits that are usually mu...l to a glass filter commonly used in laboratory re...
(Date:11/18/2008)... Research (NWO) and the Netherlands Royal Academy ...h colleagues in China to launch a new research pro...gramme (JSTP). It is the first time that NWO and t...ral cooperation with Chinese ministries and academ...t research programme during their recent working v...
(Date:11/18/2008)...Journal of Preventive Medicine special issue on c... the "Changing Climate Changing People" conferenc...uest Editor Howard Frumkin, MD, DrPH, speaking abo..., "Climate change is a key public health challen...nsequences of climate change for health, take appr...
(Date:11/17/2008)...gle flower per stalk while each stem of a tomato p...In a new study, published in this week,s issue of ...y Lippman and colleagues identify a genetic mechan...n the Solanaceae (nightshade) family of plants tha...co, petunia, and deadly nightshades. Manipulation ...
Breaking Biology News(10 mins):New filtering technology has environmental, industrial applications 2New filtering technology has environmental, industrial applications 3NWO and Academy launch research program with China 2Issues at intersection of climate change and health impact global well-being 2Issues at intersection of climate change and health impact global well-being 3Issues at intersection of climate change and health impact global well-being 4A big bunch of tomatoes? 2Clinical study shows biological and clinical activity in relapsed leukemia patients 21047 1Clinical study shows biological and clinical activity in relapsed leukemia patients 21047 2Clinical study shows biological and clinical activity in relapsed leukemia patients 21047 3Substance in red wine found to keep hearts young 3530 1Substance in red wine found to keep hearts young 3530 2Substance in red wine found to keep hearts young 3530 3Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 21046 1Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability 21046 2Retaining Employees Capacity For Work Following Sickness 21044 1Retaining Employees Capacity For Work Following Sickness 21044 2
Other Contentseukaryoteseukaryoteseukaryoteseukaryoteseustachianconservedconservedconservedconservedconservedconservedconservedevolutionarilyevolutionarilyevolutionarilyevolutionarilyexocrineexocrineexogenousexogenousexogenousexogenousexogenousexogenousexonsexonsexonsexons